Medindia LOGIN REGISTER
Medindia

Brain Chemical Identified For Drug Dependent Behavior

by Medindia Content Team on Aug 29 2005 5:57 PM

Researchers from University of Pennsylvania had identified a brain chemical responsible for some drug seeking behaviors associated with substance abuse. The chemical called orexin is also involved in feeding, arousal and sleep behaviors in human beings.

Research showed that the activation of orexin-secreting brain cells in the hypothalamus, a brain region that controls many vital functions such as eating, body temperature, fat metabolism, etc. is strongly correlated with food- and drug-seeking behaviors. Past anatomical studies have shown that these cells in the lateral hypothalamus also project to adjacent reward-associated areas of the brain.

This study suggests that orexin may be a factor in modulating reward-seeking characteristic of substance abuse. The findings help to better identify neural pathways involved in drug abuse, craving and relapse, which may ultimately help scientists find more effective therapies.

This study is published online for the August issue of the journal Nature. The hypothalamus is a small area of the brain above and behind the roof of the mouth. It is involved with the involuntary nervous system and control of processes such as fluid maintenance, sugar balance, fat metabolism, regulation of body temperature, and control of hormonal secretion. The lateral hypothalamus is referred to as the brain’s hunger center.

Researchers had found that the more animals seek out cues associated with food or drug reward, the more activated the neurons become. In rats that had their drug-seeking behavior extinguished, the preference for drug-associated cues was reinstated by chemically activating these cells and orexin production. These data suggest that this brain system may be involved in the development of drug craving that can perpetuate both addiction and relapse.

This neural system may be activated by environmental cues that cause addicts to relapse back to drug-taking behavior even after successfully going through rehabilitation and achieving abstinence.

Source: NIH


Advertisement